08:23 AM EDT, 09/19/2024 (MT Newswires) -- Vivos Therapeutics ( VVOS ) said Thursday is selling about 1.4 million common shares at $3.15 apiece in a registered direct offering for gross proceeds of roughly $4.3 million.

Priced at-the-market under Nasdaq rules, the offering is expected to close around Friday, the company said.

The company said it plans to use the net proceeds for working capital and general corporate purposes.

Shares of Vivos Therapeutics ( VVOS ) slid 23% in premarket activity on Thursday.

Price: 3.1800, Change: -0.95, Percent Change: -23.00